| First Author | Mahmood A | Year | 2022 |
| Journal | Biochem Biophys Res Commun | Volume | 637 |
| Pages | 58-65 | PubMed ID | 36375251 |
| Mgi Jnum | J:331932 | Mgi Id | MGI:7407812 |
| Doi | 10.1016/j.bbrc.2022.11.003 | Citation | Mahmood A, et al. (2022) Nmnat3 deficiency in hemolytic anemia exacerbates malaria infection. Biochem Biophys Res Commun 637:58-65 |
| abstractText | Malaria is an infectious disease caused by Plasmodium parasites and has high mortality rates, especially among children in African and Southeast Asian countries. Patients with hemolytic anemia are suggested to adapt protective measures against malarial infection. Nicotinamide adenine dinucleotide (NAD(+)) is a crucial cofactor associated with numerous biological processes that maintain homeostasis in all living organisms. In a previous study, we had demonstrated that the deficiency of nicotinamide mononucleotide adenylyltransferase 3 (Nmnat3), an enzyme catalyzing NAD(+) synthesis, causes hemolytic anemia accompanied by a drastic decline in the NAD(+) levels in the erythrocytes. It is well known that hemolytic anemia is linked to a reduced risk of malarial infections. In the present study, we investigated whether hemolytic anemia caused by Nmnat3 deficiency is beneficial against malarial infections. We found that Nmnat3 deficiency exacerbated malarial infection and subsequently caused death. Moreover, we demonstrated that the NAD(+) levels in malaria-infected Nmnat3 red blood cells significantly increased and the glycolytic flow was largely enhanced to support the rapid growth of malarial parasites. Our results revealed that hemolytic anemia induced by the deletion of Nmnat3 was harmful rather than protective against malaria. |
